Skip to main content
Top
Published in: BMC Ophthalmology 1/2024

Open Access 01-12-2024 | Fluconazole | Research

Enhanced systematic delivery of fluconazole-loaded biotin-glutathione functionalized chitosan-g-proline carrier into the infected retinitis treatment

Authors: Qing Guo, Zheng Li, Fang Cao

Published in: BMC Ophthalmology | Issue 1/2024

Login to get access

Abstract

Background

The polymer-based facile and effective drug carrier approach was developed to treat superficial fungal infected retinopathy infections.

Methods

Here, biotin-glutathione (B-GHS) functionalized with chitosan grafted proline (CS-g-P) moieties were fabricated with the loading of fluconazole (FLZ) for the treatment of retinopathy. FT-IR and XRD techniques were used to characterize chemical structural and phase changes of the prepared carriers The SEM results show that the sphere morphology with interconnection particle nature.

Results

The particle diameter was found as ~ 6.5 and ~ 8.6 nm for CS-g-P/B-GHS and FLZ-loaded CS-g-P/B-GHS carriers, respectively. The negative surface charge was found as the values of CS-g-P/B-GHS and FLZ-loaded CS-g-P/B-GHS, such as -20.7 mV and − 32.2 mV, from zeta potential analysis. The in-vitro FLZ releases from the CS-g-P/B-GHS were investigated at pH 7.4 (PBS) as the tear fluid environment, and it was observed at 85.02% of FLZ release in 8 h reaction time. The sustained release was observed, leading to the necessity for prolonged therapeutic effects. The antifungal effect of the carrier was studied by the minimum inhibitory concentration (MIC) and the percentage inhibition of viable fungal count against Candida albicans, and it observed 81.02% of the zone of inhibition by the FLZ carrier.

Conclusion

FLZ-loaded CS-g-P/B-GHS carrier could inhibit the biofilm formation in a concentration-dependent inhibition. Hence, A novel FLZ/B-GHS-CS-g-P carrier is a hopeful approach for effectively treating superficial fungal contaminations of the retina region.
Literature
4.
go back to reference Agrahari V, Mandal A, Agrahari V, Trinh HM, Joseph M, Ray A et al. Drug Deliv Transl Res 2016;6;735. Agrahari V, Mandal A, Agrahari V, Trinh HM, Joseph M, Ray A et al. Drug Deliv Transl Res 2016;6;735.
7.
go back to reference Patra JK, Das G, Fraceto LF, Ramos Campos EV, Rodriguez-Torres MP, Acosta-Torres LS, et al. J Nanobiotechnol. 2018;16:71.CrossRef Patra JK, Das G, Fraceto LF, Ramos Campos EV, Rodriguez-Torres MP, Acosta-Torres LS, et al. J Nanobiotechnol. 2018;16:71.CrossRef
8.
go back to reference Mobaraki M, Soltani M, Zare Harofte S, Zoudani LE, Daliri R, Aghamirsalim M et al. Pharmaceutics 2020;12:1232. Mobaraki M, Soltani M, Zare Harofte S, Zoudani LE, Daliri R, Aghamirsalim M et al. Pharmaceutics 2020;12:1232.
10.
11.
go back to reference Javad SR, Cristina Q, Monica B, Lia Sanda R, Oksana S, Simona S et al. Cancer Cell Int 2021;21:318. Javad SR, Cristina Q, Monica B, Lia Sanda R, Oksana S, Simona S et al. Cancer Cell Int 2021;21:318.
14.
15.
go back to reference Tardy AL, Pouteau E, Marquez D, Yilmaz C, Scholey A. Nutrients 2020;12:228. Tardy AL, Pouteau E, Marquez D, Yilmaz C, Scholey A. Nutrients 2020;12:228.
16.
go back to reference Shi C, Wang P, Airen S, Brown C, Liu Z, Townsend JH, et al. Eye Vis. 2020;7:33.CrossRef Shi C, Wang P, Airen S, Brown C, Liu Z, Townsend JH, et al. Eye Vis. 2020;7:33.CrossRef
17.
go back to reference Awais M, Abdul B, Syed Saoud Z, Muhammad WK, Sajiha B, Ehsan E, et al. J Drug Deliv Sci Technol. 2022;67:102972.CrossRef Awais M, Abdul B, Syed Saoud Z, Muhammad WK, Sajiha B, Ehsan E, et al. J Drug Deliv Sci Technol. 2022;67:102972.CrossRef
18.
go back to reference Bingbing L, Feng Z, Kai H, Yipei W, Surong M, Yikai Z, et al. Sci Rep. 2017;7:43082.CrossRef Bingbing L, Feng Z, Kai H, Yipei W, Surong M, Yikai Z, et al. Sci Rep. 2017;7:43082.CrossRef
19.
go back to reference Pradeepkumar P, Naresh Kumar R, Abdullah AA, Murugan AM, Rajan M. ACS Appl Biol Mater. 2018;1:1.CrossRef Pradeepkumar P, Naresh Kumar R, Abdullah AA, Murugan AM, Rajan M. ACS Appl Biol Mater. 2018;1:1.CrossRef
21.
go back to reference Anishiya Chella Daisy ER, Rajan M, Suganya K, et al. J Saudi Chem Soc. 2021;25:101347.CrossRef Anishiya Chella Daisy ER, Rajan M, Suganya K, et al. J Saudi Chem Soc. 2021;25:101347.CrossRef
22.
go back to reference Lijie W, Yuan C, Wenqiang T, Qing L, Guodong G, Fang D et al. Molecules 2018;23:2604. Lijie W, Yuan C, Wenqiang T, Qing L, Guodong G, Fang D et al. Molecules 2018;23:2604.
23.
27.
go back to reference Pasko MT, Piscitelli SC, Van Slooten AD. DICP 1990;24:860. Pasko MT, Piscitelli SC, Van Slooten AD. DICP 1990;24:860.
28.
go back to reference Jinwei D, Xiang G, Yimeng D, Hui Z, Jing G, Aiping Z. Asian J Pharm Sci. 2021;16:444.CrossRef Jinwei D, Xiang G, Yimeng D, Hui Z, Jing G, Aiping Z. Asian J Pharm Sci. 2021;16:444.CrossRef
29.
go back to reference Moiseev RV, Morrison PWJ, Steele F, Khutoryanskiy VV. Pharmaceutics 2019;11:321. Moiseev RV, Morrison PWJ, Steele F, Khutoryanskiy VV. Pharmaceutics 2019;11:321.
30.
go back to reference Xu Q, Kambhampati SP, Kannan RM. J Opthalmol. 2013;20:2. Xu Q, Kambhampati SP, Kannan RM. J Opthalmol. 2013;20:2.
31.
go back to reference Juergen S, Ronald AS, Florence S, editors. 2012, editors Advances in Delivery Science and Technology (Springer New York Dordrecht Heidelberg London) p 127. Juergen S, Ronald AS, Florence S, editors. 2012, editors Advances in Delivery Science and Technology (Springer New York Dordrecht Heidelberg London) p 127.
32.
go back to reference Mayer FL, Wilson D, Hube B. Virulence 2013 2013;4:119. Mayer FL, Wilson D, Hube B. Virulence 2013 2013;4:119.
33.
go back to reference Shi Q, Anishiya Chella Daisy ER, Yang G, Zhang J, Mickymaray S, Abdulaziz Alfaiz F, et al. Arab J Chem. 2021;14:103118.CrossRef Shi Q, Anishiya Chella Daisy ER, Yang G, Zhang J, Mickymaray S, Abdulaziz Alfaiz F, et al. Arab J Chem. 2021;14:103118.CrossRef
34.
go back to reference Awais Mushtaq A, Baseer SS, Zaidi MW, Khan S, Batool. Ehsan Elahi, Waqar Aman, Muhammad Naeem and Fakhar Ud Din. J Drug Deliv Sci Technol 2022;67:102972. Awais Mushtaq A, Baseer SS, Zaidi MW, Khan S, Batool. Ehsan Elahi, Waqar Aman, Muhammad Naeem and Fakhar Ud Din. J Drug Deliv Sci Technol 2022;67:102972.
36.
go back to reference Ayala A, Muñoz MF, Argüelles. S Oxid. Med. Cell Longev. 2014;2014:360438. Ayala A, Muñoz MF, Argüelles. S Oxid. Med. Cell Longev. 2014;2014:360438.
Metadata
Title
Enhanced systematic delivery of fluconazole-loaded biotin-glutathione functionalized chitosan-g-proline carrier into the infected retinitis treatment
Authors
Qing Guo
Zheng Li
Fang Cao
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Fluconazole
Published in
BMC Ophthalmology / Issue 1/2024
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-024-03305-z

Other articles of this Issue 1/2024

BMC Ophthalmology 1/2024 Go to the issue